During the ATS 2023 Respiratory Innovation Summit, APIE Therapeutics presented a poster demonstrating preclinical efficacy of APT101 in a lung fibrosis model
Read MoreEvents
IPF Summit 2022
During the IPF Summit, APIE Therapeutics presented a poster describing the novel apelin receptor agonist (APT101) and its effects in models of acute and chronic...
Read MoreInternational Workshop of Scleroderma Research
Preclinical results support the potential of APT-101 as a therapeutic for ILD, including those cases associated with SSc-ILD
Read MoreAPIE Therapeutics chosen as Start-Up Stadium
Start-Up Stadium was designed to provide start-up companies with the opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and...
Read MoreRESI JPM 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors with strategic channel partners. In 2022, RESI returns to JP Morgan in...
Read MoreRESI Conference 2021
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors with strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners...
Read MoreLongevity Health & Innovation Conference
Longevity, Health & Innovation (LHI) is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their...
Read MoreVenture Connect 2021
Venture Connect Online is a digital experience that is designed to maximize the visibility of growing companies and help entrepreneurs build relationships with people (investors,...
Read More